• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

AI and Machine Learning

The latest news on AI and machine learning in pharma — from drug discovery and clinical trials to commercial strategy and FDA-backed innovation.

Marc Tessier-Lavigne
Biotech

Buzzy AI biotech Xaira unveils antibody platform ambitions

CEO Marc Tessier-Lavigne, Ph.D., told Fierce of Xaira's “major focus to develop a model that can design antibodies that are drug-ready from the start”
Darren Incorvaia Oct 2, 2026 11:00am
Genentech

Genentech inks $1.5B bispecific pact with fast-rising Earendil

Sep 25, 2026 2:51am
federal website NIH

NIH debuts tool to help scientists navigate biomedical database

Sep 24, 2026 2:00pm
Robot hands with a pieces of the puzzle

Boehringer, Envisagenics ink $1B multi-target oncology collab

Sep 22, 2026 8:00am
IPO initial public offering Wall Street

Iambic maintains momentum from Big Pharma collabs with IPO plans

Sep 22, 2026 3:14am
Absci headquarters in Vancouver Washington

Inside Absci's quest to become the Apple of biotech

Sep 2, 2026 3:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings